Table 2.
Information on the four Nordic countries programme implementation culled from the 2017 WHO EU Meeting Report and Vaccarella et al. (2014) study
| General information | Programme organisation | Programme monitoring and quality assurance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Country | Description of national screening activities | Target age (y) | Screening interval (y) | Screening activities | Is there a national screening policy documented as a law or an official recommendation? | Is there a team responsible for implementing the policy? | Are the screening tests provided free of charge? | Does the programme issue individual invitations through the screening registries? | Is there a team responsible for quality assurance? | Are screening data collected, linked to screening registries with programme performance reports published? |
| Finland | 1963 | 30–641 | 5 | National, population-based | OR | ✓ | ✓ | ✓ | ✓ | ✓ |
| Sweden | 1967 | 23–60 | 3 (23–50); 5 (51–60) | National, population-based | OR | ✓ | ✓ | ✓ | ✓ | ✓ |
| Norway | 1995 | 25–69 | 3 | National, combination of opportunistic and organised activities | OR | ✓ | ✗ | ✓ | ✓ | ✓ |
| Denmark | 1967 | 23–59 (HPV test: 60–65) | 3 (23–59); 5 (60–64) | Regional until 1996; now national and population-based | OR | ✓ | ✓ | ✓ | ✓ | ✓ |
✗ = NO;
✓ = YES;
1Some municipalities target women below 30 years and above 60 years
3OR=Official recommendation